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Abstract
Objective: To determine the prevalence and severity of drooling in infant cerebral palsy (ICP) and analyze the possible 
surgical, pharmacological, myofunctional and novel alternative approaches to treatment of this disorder.
Methods: A clinical study is made of a group of patients with ICP (cohort) and aged between 4 and 34 years, visi-
ting a dental clinic for disabled patients. The classification of Thomas-Stonell and Greenberg was used to assess the 
presence and severity of drooling.
Results: Of the total of 50 patients evaluated (52% males and 48% females), 58% presented drooling (mild in 44.4% 
and moderate to severe in 27.7%).
Conclusion: Over half  of the patients with ICP presented drooling. Effective options are therefore needed for the 
treatment of this problem, which poses a series of negative effects for both patients and their care givers.
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Introduction
Infant cerebral palsy (ICP) comprises a group of  mo-
vement and postural development disorders that cause 
disability, and which originate during development of 
the fetal brain (1).
Despite progress in the prevention and treatment of certain 
causes of cerebral palsy, the number of affected children 
and adults has remained relatively constant or has even 
increased slightly in the last 30 years. This is because more 
critical premature and weak infants survive as a result of 
improved neonatal care (2,3).
Drooling is defined as an unintentional loss of saliva from 
the mouth, and is considered normal in infancy up until 
the age of 18 months when the oral motor muscles matu-
re. Drooling beyond this age is not normal, and is often 
associated with neurological problems such as cerebral 
palsy or mental retardation (4-6).
Drooling manifests as an excessive output of saliva from 
the mouth secondary to alterations in voluntary oral mo-
tor activity, incorrect swallowing, or deficient lip sealing; 
in rare instances it is attributable to hypersialia - generally 
produced by the administration of antiseizure drugs or 
other psychoactive substances. Additional influencing 
factors are the emotional state of the patient, head posture, 
concentration capacity, dental malformations, the size con-
trol of the tongue, and deficient nasal respiration (7).
Patients with ICP generally present an intact swallowing 
reflex, though with a diminished capacity to control the 
initial voluntary preparatory phase, and a lack of  co-
ordination of the muscle activation sequence. Likewise, 
affected patients have problems coordinating swallowing 
and breathing, and this in turn may inhibit the swallowing 
reflex when the mouth is full of saliva - thus resulting in 
drooling (7-9). 
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Among the classifications of  the severity of  drooling, 
Thomas-Stonell and Greenberg in 1988 (4) defined five 
grades (Table 1).
The management of drooling in children with neurological 
problems has received increased attention in recent years, 
and in fact an increased range of treatment options is 
presently available for such patients.
Surgery was one of the first options contemplated for the 
treatment of drooling. The principal surgical techniques 
comprised salivary duct relocation or ligation, or the 
removal of gland tissue. Chang et al. (4) relocated the 
submandibular gland duct and removed the sublingual 
glands, reporting excellent clinical results after the sur-
gical procedure. However, side effects such as the loss 
of sphincter function after relocation of the orifice, and 
ranula formation, are problems that must be taken into 
account.
Bilateral relocation of the submandibular gland ducts is 
used, and tends to cause few adverse effects. The subman-
dibular ducts are exteriorized to the oral cavity beneath 
the tongue, immediately below the lower teeth. Posteriorly, 
a tunnel is made on the floor of the mouth towards the 
tonsillar region, alongside the posterior portion of the 
tongue and towards the pharynx. Finally, the ducts are 
positioned through the tonsils and sutured; since they 
face towards the back of the mouth, swallowing of the 
saliva is facilitated (6).
More recently, intraductal laser photocoagulation of the 
parotid ducts has been proposed. This technique requires 
general anesthesia. The parotid duct is located and dila-
ted with a catheter, after which an optic fiber measuring 
600 µm in diameter is inserted from the intraoral orifice 
towards the terminal duct of the parotid gland. Finally, 
laser photocoagulation is carried out during 10 seconds 
at a power rating of 7 W in patients under 5 years of age 
(versus 10 W for older patients). In a clinical study ca-
rried out by Chang et al. (4), involving 48 patients, 83.3% 
showed significant reduction in drooling, and no patient 
presented signs of xerostomia (4).
Other treatment options involve drugs used to reduce 
saliva volume without altering swallowing function. In 
this context, cholinergic muscarinic receptor block reduces 
saliva output. However, a series of both local and central 
side effects may result, such as drowsiness, irritability, rapid 
mood changes, hostile behavior, fear, deficient coordina-
tion, nasal congestion, xerostomia, vomiting, diarrhea and 
bladder voiding difficulties. 
Among the anticholinergic drugs used to control drooling, 
mention should be made of atropine sulfate, glycopyrrola-
te and scopolamine. The undesirable effect of these drugs 
is the pharmacological action sought in this case.
Mier et al. (5) conducted a double blind study involving 
39 children administered either glycopyrrolate or placebo. 
The patients received body weight adjusted doses that in 
turn were subjected to four-fold increments. The results 
showed considerable improvement in drooling, particu-
larly with the last treatment dose, while in contrast the 
greatest side effects were also noted with the third and 
fourth doses.
Regarding the use of transdermal scopolamine, the latter 
drug has been shown to offer a number of advantages 
over other alternatives, including easy administration, 
prolonged action (no patch replacement being needed in 
72 hours), and a low incidence of side effects compared 
with other drugs exerting anticholinergic actions. While 
affording the same anticholinergic effects as any other 
anticholinergic agent, scopolamine offers the advantage 
of more potent action upon the salivary glands, with les-
ser action upon the heart and intestinal smooth muscle 
(5,10,11).
Botulin vaccine is presently used in fields such as neu-
rology. It is employed as treatment for disorders such as 
cerebral palsy, tremor, bruxism, spasticity, rigidity and 
muscle dystonia. Its local administration allows precise 
selection of the muscle groups exhibiting hyperactivity 
requiring control via individualized doses, depending 
on the intensity of the disorder. The effect is local and 
reversible, yet sufficiently prolonged to allow repeated 
administration without the risk of side effects. The ade-
quate use of this vaccine could improve patient quality of 
life by reducing the contractures and articular alterations 
that favor drooling (12).
Another management option is the so-called Baba Stop 
(13). This is a behavior modifying program developed 
for children with ICP that have good comprehension of 
verbal instructions and are amenable to social reinforce-
ment efforts, in accordance to the existing cognitive level. 
Conditioning is based on the use of a temporizer that 
generates an acoustic, visual or tactile stimulus at fixed or 
variable time intervals. During the conditioning phase, the 
therapist gives instructions to the child to close the mouth 
and swallow when the conditioning stimulus is generated. 
This program was evaluated in a study of 12 patients, with 
positive results in all cases - though to variables degrees. 
Thus, drooling practically disappeared in some children, 
Grade Description 
1 Dry, no drooling 
2 Mild: humid lips only 
3 Moderate: humid lips and chin 
4 Severe: clothing begins to be affected 
5 Profuse: clothes, hands and objects are wet 
Table 1. Drooling severity classification according to Thomas-
Stonell and Greenberg.
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while others showed a decrease and some proved able 
to control the problem; however, when the conditioning 
stimulus disappeared, drooling gradually returned. For 
this reason a portable temporizer was developed that is 
currently being evaluated. The most important considera-
tion is that the patients can learn to swallow, after which 
the temporizer reminds them when to do so.
Finally, mention should be made of myofunctional thera-
py, which comprises a series of procedures and techniques 
used for the correction of orofacial muscle imbalance, 
the creation of new and normal muscular behavior, the 
reduction of negative habits, and improvement of patient 
esthetics (14). 
Early myofunctional therapy in patients with ICP is very 
important in order to normalize respiration, swallowing 
and chewing as far as possible, and thus facilitate eating. 
Following thorough anamnesis and a good clinical exami-
nation, a program individualized to meet the requirements 
of each patient is established, involving a series of exercises 
targeted to concrete muscle groups. These exercises are 
gradually intensified in terms of number and difficulty 
as the patient improves. Castillo-Morales (15) proposed 
a combination of muscle exercises and specific functional 
orthopedic devices for each type of cerebral palsy.
Patients and Methods
The study group consisted of 50 patients with ICP and 
seen in a dental clinic for disabled patients, over a period 
of 8 months. There were 26 males (52%) and 24 females 
(48%). The inclusion criterion was a medical diagnosis of 
ICP. A case history was compiled, including patient data, 
associated diseases and the pharmacological treatment 
used. Information was also collected during the examina-
tion, related to the presence or absence of drooling and 
of  other characteristics or anatomical alterations that 
contribute to the appearance of drooling. In this context, 
the 0-1-2 malocclusion index (MOI) of the World Health 
Organization was used, among other parameters:
Score 0: no anomalies or malocclusions. 
Score 1: discrete anomalies, ≥ 1 rotated teeth, mild 
crowding or spacing. 
Score 2: severe malocclusions.
In addition, sagittal anomalies were examined (molar and 
canine class according to the Angle classification), together 
with vertical anomalies including open bite and overjet, 
and transverse anomalies including crossbite. 
Informed consent was obtained from the patient tutors for 
the evaluation, in compliance with the ethical norms of 
the institution. Likewise, the parents or care givers were 
questioned about the frequency of drooling, to contrast 
this information with that obtained in the clinic. The cli-
nical evaluation was carried out by a single operator with 
the purpose of standardizing the results obtained.
After determining the presence or absence of drooling, the 
severity of the latter was assessed (Figures 1 and 2), based 
on the classification of Thomas-Stonell and Greenberg 
(Table 1).
Posteriorly, the data were tabulated and graphically re-
presented to obtain the percentage results regarding the 
presence of drooling and its severity in the studied patient 
group. Statistical analysis (using the SPSS version 12 
statistical package) yielded the absolute and percentage 
frequencies, and the association of qualitative variables 
was carried out by means of the chi-square test.
Results
Of the 50 patients with ICP included in the study, 26 were 
males (52%) and 24 females (48%), with an age range of 
4-34 years (mean 15.5 years). A total of 29 cases suffered 
drooling (58%) to some degree within the classification 
of Thomas-Stonell and Greenberg, while 21 did not have 
this problem.
Mild drooling was recorded in 38.88% of the cases, while 
the remaining 61.11% drooling proved moderate or severe 
(grades 3 and 4). None of the patients presented grade 5 
drooling according to the above classification.
1
 Figura 1. Paciente con PCI. F lta de sellado labial  y babeo severo 
Figura 2. Paciente con PCI. Mordida abierta anterior y babeo leve. 
1
 Figura 1. Paciente con PCI. Falta de sellado labial  y babeo severo 
Figura 2. Paciente con PCI. Mordida abierta anterior y babeo leve. 
Fig. 1. Patient with ICP. Lack of lip sealing and severe drooling.
Fig. 2. Patient with ICP. Anterior open bite and mild drooling.
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Forty percent of the patients had a history of seizures, 
and in all these cases antiseizure medication was being 
prescribed. Of the 20 patients with such seizure antece-
dents, 17 (85%) suffered drooling while 3 (15%) did not. 
Comparison of these results by means of the chi-square 
test yielded significant differences (p=0.01).
On examining the presence of malocclusions related to 
the presence of drooling, we found that 15 patients had 
anterior open bite without lip sealing capacity; all but 
3 cases (80%), suffered drooling to one degree or other 
(p=0.04). Three cases presented Angle class II (one case 
with overjet, another division 2 with overbite, and a third 
patient with edge-to-edge bite). One subject in the study 
also presented a class III molar relationship.
In the 30 patients without malocclusions, 14 suffered 
drooling. Likewise, on evaluating anomalous habits, 6 
individuals showed some degree of bruxism, and in all of 
them clinical drooling was observed.
Discussion
Drooling is the unintentional loss of  saliva from the 
mouth, and is normal in infancy up to the age of 15-30 
months maximum. Thus, from the youngest age in our 
series (4 years), drooling is considered pathological (4,5). 
The presence of drooling in patients with ICP is not at-
tributable to an excess production of saliva but mainly to 
a defect in swallowing (9).
Drooling poses important social limitations for many 
patients with neurological problems. In the present study, 
the disorder affected over half  of all subjects (58%), in 
coincidence with the observations of Tahmassebi et al. 
(16), and exceeding the prevalences of 10% and 10-37% 
respectively reported by Dreyfuss et al. (10) and Mier et 
al. (5), respectively. 
Other factors can be association to the etiology of drooling, 
such as antiseizure medication. In the present study, 40% 
of the patients had a history of seizures, in coincidence 
with the figures reported in the literature, where between 
30% and 50% of all patients with ICP suffer seizures (16-
18). This in turn requires the prescription of drugs which 
according to Sochaniwskyj (7) can contribute to excessive 
saliva production, and thus to a rise in the prevalence of 
drooling. In our case, most of the patients taking such 
medication (85%) suffered drooling.
The presence of malocclusions such as anterior open bite, 
lip hypotonicity and lingual incompetence complicate 
lip sealing and transport of the food bolus towards the 
posterior zone of the oral cavity. The initiation of swallo-
wing is complicated as a result (7,19,20). Tahmassebi and 
Luther (20) have pointed to a possible association between 
lip sealing and the presence of drooling in children with 
ICP (20).
 Vertical malocclusions such as open bite and overjet show 
an increased prevalence in the population with infant ce-
rebral palsy. In this study, 30% of the sample had anterior 
open bite, in coincidence with the observations published 
by Giménez et al. (21) - with a prevalence of 62%. We 
observed a strong association between the presence of 
clinical drooling and anterior open bite with difficulties 
for lip sealing.
The high incidence of drooling in patients with ICP makes 
it necessary for the specialist to know and offer treatment al-
ternatives based on the situation of each individual patient, 
with the aim of improving health (22) and quality of life.
Conclusions
The present study shows that the presence of drooling can 
be related to a number of factors, including antecedents 
of seizures and the use of antiseizure drugs, the presence 
of  malocclusions such as anterior open bite and, and 
problems for effective lip sealing.
 
References
1. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et 
al. Proposed definition and classification of cerebral palsy, April 2005. 
Dev Med Child Neurol. 2005 Aug;47(8):571-6. 
2. Reddihough DS, Collins KJ. The epidemiology and causes of cerebral 
palsy. Aust J Physiother. 2003;49(1):7-12. 
3. Silvestre FJ. Pacientes con Parálisis Cerebral. En: Odontología en 
pacientes discapacitados. Silvestre FJ editors. Valencia: Laboratorios 
Kin, S.A; 2004. p. 79-86.
4. Chang CJ, May-Kuen Wong AA. Intraductal laser photocoagulation 
of the bilateral parotid ducts for reduction of drooling in patients with 
cerebral palsy. Plast Reconstr Surg. 2001 Apr 1;107(4):907-13. 
5. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treat-
ment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging 
study. Arch Pediatr Adolesc Med. 2000 Dec;154(12):1214-8. 
6. Yam WK, Yang HL, Abdullah V, Chan CY. Management of drooling 
for children with neurological problems in Hong Kong. Brain Dev. 2006 
Jan;28(1):24-9. 
7. Sochaniwskyj AE, Koheil RM, Bablich K, Milner M, Kenny DJ. Oral 
motor functioning, frequency of swallowing and drooling in normal 
children and in children with cerebral palsy. Arch Phys Med Rehabil. 
1986 Dec;67(12):866-74. 
8. Love RJ, Webb WG. Neurología para los especialistas del habla y del 
lenguaje. 3rd ed. Madrid: Editorial Médica Panamericana; 2001.
9. Tahmassebi JF, Curzon ME. The cause of drooling in children with 
cerebral palsy -- hypersalivation or swallowing defect. Int J Paediatr 
Dent. 2003 Mar;13(2):106-11. 
10. Dreyfuss P, Vogel D, Walsh N. The use of transdermal scopolami-
ne to control drooling. A case report. Am J Phys Med Rehabil. 1991 
Aug;70(4):220-2. 
11. Palau Galindo A, Ciutat Benet M, Fernández González A, Planellas 
Boix M. Therapeutic utility of a side-effect to control sialorrhoea. Aten 
Primaria. 2004 Jun 15;34(1):55. 
12. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection 
of botulinum toxin A as a treatment to control sialorrhea in children with 
cerebral palsy. Am J Phys Med Rehabil. 2004 Apr;83(4):304-11. 
13. Alcantud-Marin F, Ballester-Ferrer F, Hila-Vargas C.  Programa 
de condicionamiento para la instauración del control del babeo: Baba-
Stop. Valencia: Universitat de València, Estudi General; 2005. p. 3-73.
14. Borrás S, Rossel V. Logopedia e intervención. Guía para la reedu-
cación de la deglución atípica y trastornos asociados. Valencia: Nau 
llibres; 2005. p. 16.
15. Limbrock GJ, Hoyer H, Scheying H. Drooling, chewing and swallo-
wing dysfunctions in children with cerebral palsy: treatment according to 
Castillo-Morales. ASDC J Dent Child. 1990 Nov-Dec;57(6):445-51. 
16. Tahmassebi JF, Curzon ME. Prevalence of drooling in children with 
cerebral palsy attending special schools. Dev Med Child Neurol. 2003 
Sep;45(9):613-7. 
E26
Med Oral Patol Oral Cir Bucal. 2008 Jan1;13(1):E22-6.                                                                                                                                                                                     Drooling in infant cerebral palsy                                                                            Med Oral Patol Oral Cir Bucal. 2008 Jan1;13(1):E22-6.                                                                                                                                                                               Drooling in infant cerebral palsy
      
17. Hernandez G, Bonilla A, Torres M. Guías de manejo en estomato-
logía pediátrica. Bogotá: ECOE Ediciones; 1998. p. 181-4.
18. Cruz G, Vadillo F. Epilepsia y discapacidad. Barcelona: Viguera 
Editores; 2005. p. 3-21.
19. Rodrigues dos Santos MT, Masiero D, Novo NF, Simionato MR. 
Oral conditions in children with cerebral palsy. J Dent Child (Chic). 
2003 Jan-Apr;70(1):40-6. 
20. Tahmassebi JF, Luther F. Relationship between lip position and 
drooling in children with cerebral palsy. Eur J Paediatr Dent. 2004 
Sep;5(3):151-6. 
21. Gimenez MJ, López J, Boj JR. Estudio de las maloclusiones en una 
población con parálisis cerebral. Rev Iberoam Ortod 2002; 21: 33-41.
22. Llena-Puy C. The rôle of saliva in maintaining oral health and as 
an aid to diagnosis. Med Oral Patol Oral Cir Bucal. 2006 Aug;11(5):
E449-55. 
 
